AU Patent

AU2016204432B2 — Process for making benzoxazepin compounds

Assigned to F Hoffmann La Roche AG · Expires 2017-12-07 · 8y expired

What this patent protects

-44 Abstract Processes are described for the preparation of P13K inhibitor, GDC-0032, Formula I, having the structure: -N 5 I (GDC-0032), and intermediates useful for the preparation of I.

USPTO Abstract

-44 Abstract Processes are described for the preparation of P13K inhibitor, GDC-0032, Formula I, having the structure: -N 5 I (GDC-0032), and intermediates useful for the preparation of I.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016204432B2
Jurisdiction
AU
Classification
—
Expires
2017-12-07
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.